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Introduction
Metabolic syndrome (MS) is characterized by a cluster of related morbidities that includes abdominal obesity, elevated blood pressure, dyslipidaemia, insulin resistance (IR) and its hepatic component, non-alcoholic fatty liver disease (NAFLD; Arulanandan et al. 2015) . High intake of dietary carbohydrates, especially fructose, has been found to contribute to the development of metabolic alterations and cardiovascular disease (Douard & Ferraris, 2013; Softic et al. 2016) . In this sense, fructose overload in drinking water or chow has been used as a cardiometabolic damage model in rodents and, more recently, as a suitable model for NAFLD (Kawasaki et al. 2009; Softic et al. 2016) .
In previous studies of fructose-fed animals, IR was proposed as the key mediator of these features and contributes to the development of NAFLD in multiple ways. First, IR may increase the synthesis of triacylglycerol (TAG), leading to excessive amounts of fat in the liver (Kawasaki et al. 2009; Schultz et al. 2013) . Second, IR may be responsible for stimulating the production of pro-inflammatory adipocytokines, such as tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6; Basaranoglu et al. 2013; Ibrahim et al. 2015) . Third, there is a reduced ability of insulin to suppress regulatory enzymes involved in gluconeogenesis, namely glucose 6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK), thus disturbing hepatic glucose homeostasis and de novo lipogenesis (Bezerra et al. 2000; Schultz et al. 2013) .
Previous studies indicate that activation of the reninangiotensin system (RAS) is closely related to the co-morbidities of MS and appears to be a key mediator of local tissue control (Prasad & Quyyumi, 2004; Frantz et al. 2013) . The classic RAS cascade depends on angiotensin-converting enzyme (ACE)-mediated conversion of angiotensin (Ang) I into Ang II and subsequent binding to the Ang II type 1 receptor (AT1R). This ACE/AT1R axis contributes to inflammation, oxidation and IR (Velloso et al. 2006; Santos et al. 2008a) . In the present view of the RAS, another counter-regulatory axis consists of ACE2, an ACE homologue enzyme, which metabolizes Ang I (indirectly) or Ang II (directly) into Ang(1-7), which in turn binds to the Mas receptor. This ACE2/Ang(1-7)/Mas axis induces responses in opposition to the deleterious effects of ACE/Ang II/AT1R overactivity (Giani et al. 2009; Cao et al. 2014) . Some studies have revealed that RAS imbalance appears to promote hepatic disease, whereas activation of the ACE2/Ang(1-7)/Mas axis is able to prevent it (Frantz et al. 2014; Cao et al. 2016) .
Regular physical activity has been considered pivotal in the treatment of MS because it can counteract each one of these elements. Chronic exercise clearly improves IR, ectopic fat deposition and chronic inflammation (Kawamura et al. 2002; Machado et al. 2014) . Some effects of exercise training on the RAS have also been reported, as follows: reduced plasma Ang II concentrations (Mousa et al. 2008) ; decreased ACE and Ang II concentrations in cardiac muscle (Fernandes et al. 2011) ; and a shift in the RAS towards the ACE2/Ang(1-7)/Mas axis in skeletal muscle (Gomes-Santos et al. 2014) . However, the effects of exercise training on the RAS in hepatic tissue are currently unknown.
Thus, the aim of this study was to provide original evidence on the effects of exercise training on the systemic and hepatic RAS, glucose and lipid metabolism, liver injuries and inflammation induced by fructose drinking in male rats.
Methods

Ethical approval
Animal care and procedures were in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH guide, 8th edition, 2011) . The investigators understand the ethical principles under which the journal operates, and this work complies with the journal's animal ethics checklist. The Animal Care and Animal Ethics Committee of the Fluminense Federal University approved the study (protocol no. CEUA466/2013). Adult male Wistar rats (10 weeks of age) were obtained from the Laboratory Animals Core (Nucleo de Animais de Laboratorio) of Fluminense Federal University. Rats were housed in rooms with a controlled temperature (22 ± 2°C) and with 12 h-12 h light-dark cycles. Rats were fed commercial chow (Nuvilab R ; Colombo, PR, Brazil) with free access food and water. At the end of the experimental period, the rats were anaesthetized with ketamine (80 mg kg −1 ) and xylazine (12 mg kg −1 ) (Syntec, Santana de Parnaiba, SP, Brazil) I.P. and killed by exsanguination.
First, the rats were randomly assigned into two groups for a period of 2 weeks: the control group (CT, n = 16) and the high-fructose group (HFr, n = 16). Fructose overload was performed via dilution of D-fructose (Sigma Aldrich, St Louis, MO, USA) in the drinking water (100 g l −1 ); control animals received only water during the entire experimental period (Zhao et al. 2009; Morvan et al. 2013) . After 2 weeks, the rats were randomly subdivided into four groups (n = 8 each group) for an exercise training protocol over 8 weeks, as follows: untrained control group (CT); exercise control group (CT-Ex); untrained high-fructose group (HFr); and exercise high-fructose group (HFr-Ex).
The food and water intake were evaluated weekly. Energy intake was measured as the product of food consumption by the energy content of the diet/fructose. The body mass (BM) of the animals was measured weekly during the entire experimental period (2 + 8 weeks).
Maximal treadmill exercise test
Initially, the animals were adapted to a treadmill (5 min day −1 ; four sessions, once a week; from 5 to 16.7 m min −1 progressively) and were submitted to a maximal treadmill exercise test. This test was performed to determine individual aerobic capacity and aerobic exercise training intensity at pre-and post-training, using an initial velocity of 16.7 m min −1 followed by increments of 1.7 m min −1 every 2 min. The test ended when animals were exhausted, i.e. until they were not able to run and remained at the end of the mat even after 10 gentle mechanical stimuli (Brooks & White, 1978; Medeiros et al. 2016) . No electric shocks were used during the treadmill exercise test.
Exercise training protocol
After 2 weeks of water consumption or fructose overloading (CT-Ex and HFr-Ex groups, respectively), the exercise training was initiated and accomplished on a motor treadmill (Inbrasport, RS, Brazil) at a moderateintensity (50-75% of maximal running speed), from 0 to 7% inclination, for 8 weeks, 60 min day −1 and 4 days each week (Medeiros et al. 2016) .
Insulin sensitivity
An I.P. insulin tolerance test was performed after 5 h of food deprivation. A drop of blood was collected through a little incision on the tail tip to measure the blood glucose concentration using an Accu-Chek glucometer (Roche Diagnostics) before and 15 min after insulin injection (0.75 U kg −1 , I.P.; Humulin R; Lilly, Sao Paulo, SP, Brazil). The insulin sensitivity index (K i ) was evaluated as the rate of change in glucose over the first 15 min: (Schreyer et al. 1998) . As K i reflects the rate of glucose removal, larger values indicate greater tissue insulin sensitivity (Osundiji et al. 2012) .
Tissue and blood extraction
Three days after the last exercise section, the rats were anaesthetized with ketamine (80 mg kg −1 ) and xylazine (12 mg kg −1 ) (Syntec, Santana de Parnaiba, SP, Brazil)
I.P. Cardiac puncture was performed to collect blood and then the rats were killed by exsanguination. The serum was separated by centrifugation (750g for 15 min). The liver was dissected and weighed. Several liver fragments were fixed in a solution of formaldehyde for analysis by light microscopy. Other liver fragments were snap-frozen and stored at −80°C until protein expression analyses or measurement of hepatic TAG and glycogen levels.
Metabolic data
Serum insulin concentrations were measured using an ELISA kit (EZRMI-13K; Millipore, Darmstadt, Germany). The serum and hepatic TAG and hepatic glycogen were measured by colorimetric enzymatic assay kits (87-2/100 and 133-1/500, respectively; Labtest, MG, Brazil) and measured with an automated spectrophotometer (BioTek, Winooski, VT, USA), according to a protocol published previously (Fraulob et al. 2012) .
Liver histopathology
Fixed liver samples were embedded in paraffin, and 3-μm-thick sections were stained with Haematoxylin and Eosin. Digital images were acquired at random (Nikon Microscope Eclipse 80i, NY, USA). Fifteen images per animal were studied to assess the hepatic lipid accumulation (steatosis). Briefly, we used a 36-point test system (P T ) produced by the STEPanizer Web-based software (Tschanz et al. 2011 
Serum and liver ACE and ACE2 activities
The ACE and ACE2 activities were determined in serum and hepatic tissue using fluorescent substrates as previously reported (Carmona et al. 2006) . Frozen hepatic tissue samples (60 mg) were homogenized in 0.1 M Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and centrifuged at 1000 g for 10 min at 4°C. The assays were performed at 37°C in 0.1 M Tris-HCl buffer, pH 7.0, containing 50 mM NaCl and 10 mM ZnCl 2 , and captopril 0.5 μM as an inhibitor in negative samples. The hydrolysis rate of the intramolecularly quenched fluorogenic Exercise training modulates hepatic renin-angiotensin system substrate Abz-FRK-(Dnp)P-OH (10 μM) incubated with aliquots of homogenate and serum for 30 min at 37°C was assessed to obtain ACE enzymatic activity (420 and 320 nm, read in 90 cycles). The protein content was determined by the Bradford method using bovine serum albumin as the standard (Bio-Rad Protein Assay, Hercules, CA, USA). The ACE2 activity was determined in serum and in hepatic tissue using the same method described above, except that Abz-APK(Dnp)-OH was used as the fluorescent peptide, in 0.2 M Tris-HCl buffer, 200 mM NaCl, pH 7.5, and DX600 1 mM as the inhibitor.
Western blotting analysis
Approximately 100 mg of liver tissue was homogenized in radioimmunoprecipitation assay (RIPA) buffer supplemented with protease and phosphatase inhibitors. The homogenates were centrifuged (5000 g for 20 min at 4°C) and the supernatants collected. The lysate protein concentration was determined using a BCA protein assay kit (Thermo Scientific, Waltham, MA, USA). After denaturation, proteins were separated by PAGE and transferred to a polyvinyldifluoride membrane (Amersham Biosciences, Piscataway, NJ, USA). The membrane was then blocked by incubation in 5% bovine serum albumin (BSA) in Tris-buffered saline and sequentially incubated overnight at 4°C with the following primary antibodies: ACE (ab11734; Abcam, Cambridge, MA, USA; 1:500), AT1R (SC579; Santa Cruz Biotechnology, Dallas, TX, USA; 1:500), ACE2 (ab108252; Abcam; 1:200), Mas receptor (SC135063; Santa Cruz Biotechnology; 1:500), PEPCK (SC32879; Santa Cruz Biotechnology; 1:1000), G6Pase (SC25840; Santa Cruz Biotechnology; 1:1000), glucose transporter (GLUT) 2 (SC9117; Santa Cruz Biotechnology; 1:1000), TNF-α (SC1350; Santa Cruz Biotechnology; 1:500) and IL-6 (ab1423; Abcam; 1:1000). After incubation with the primary antibody, the membrane was incubated with the secondary antibody for 1 h at room temperature (anti-mouse, SC2005, Santa Cruz Biotechnology, 1:5000 for ACE; anti-rabbit, SC2004, Santa Cruz Biotechnology, 1:10000 for AT1R, ACE2, Mas receptor, PEPCK, G6Pase, GLUT2 and IL-6; anti-goat, SC2768, Santa Cruz Biotechnology, 1:10000 for TNF-α and cyclophilin). The membrane was developed using enhanced chemiluminescence (ECL) Western blotting detection reagents, and images of the blot were obtained with Bio-Rad's Molecular Imaging ChemiDoc XRS Systems (Bio-Rad). The intensity of the chemiluminescent bands was quantified using ImageJ software, version 1.44 (NIH, Bethesda, MD, USA; imagej.nih.gov/ij,). The blots were stripped and reprobed for cyclophilin (anti-goat, SC20361; Santa Cruz Biotechnology; 1:1000) as a loading control for proteins.
Quantification of angiotensin by HPLC
The concentration of Ang II and Ang(1-7) was quantified by HPLC. Liver samples were quickly harvested, rinsed, and 25 mg was homogenized in vortex for 1 min with 0.1 M sodium phosphate buffer, pH 7.2, containing 0.34 M sucrose and 0.3 M NaCl. After centrifugation at 3000 g for 10 min (Oliveira et al. 2000) , angiotensins from supernatants were extracted by Oasis HBL 3cc columns (Waters, Dublin, Ireland) previously activated with methanol (5 ml), tetrahydrofuran (5 ml), hexane (5 ml), methanol (5 ml) and water (10 ml). After sample introduction, columns were washed with water (10 ml), and peptides of interest were eluted with 1 ml of a mixture of ethanol, acetic acid and water (90:4:6). The eluted fractions were evaporated to dryness under a stream of nitrogen and resuspended in 500 μl mobile phase A (Bertoncello et al. 2015) . The chromatographic separation of 20 μl was achieved by HPLC (Shimadzu System, Kyoto, Japan) in a reverse phase column 300SB C8 (150 mm length × 4.6 mm inner diameter, 5 μm particle size). A mobile phase composed of ultrapure water and acetonitrile with 0.1% trifluoroacetic acid (TFA; 95:5, v/v; A) and ultrapure water and acetonitrile with 0.085% TFA (5:95, v/v; B) was used. Detection was performed in the ultraviolet range at 215 nm, and the column temperature was maintained with a thermostat at 40°C. The elution program consisted of a flow rate of 1.0 ml min −1 and a linear gradient system with 0-60% B in 60 min. The angiotensins were identified by retention time and quantified by peak area using standard curves integrated into LC Solution software (Shimadzu System, Kyoto, Japan). The column wash and white samples were injected into HPLC for analysis. The only samples detected with angiotensin were in the standard samples.
Statistical analysis
The differences among the groups were tested by one-way ANOVA followed by the Holm-Sidak post hoc test. Two-way ANOVA was performed to identify the interactions between effects on body mass, energy intake and aerobic capacity. Intragroup differences between preand post-training times were tested by Student's unpaired t test with Welch's correction. Data are reported as the means ± SD. In all instances, P < 0.05 was considered statistically significant (GraphPad Prism version 6.01 for Windows; GraphPad, La Jolla, CA, USA).
Results
Body mass gain and energy intake
The BM gain was constant in all groups throughout the experimental period. At the end of the study, BM remained similar among the groups: CT (431.5 ± 31.9 g), CT-Ex E. D. C. Frantz and others 
11.1 ± 1.9 9.3 ± 4.5 26.1 ± 6.5 * † 13.9 ± 3.3 ‡ Abbreviations: CT, control; CT-Ex, exercise control; HFr, high fructose; HFr-Ex, exercise high fructose; and K i , insulin sensitivity index.
Values represent means ± SD, n = 8 per group. * P < 0.05 compared with the CT group. † P < 0.05 compared with the CT-Ex group. ‡ P < 0.05 compared with the HFr group. § P < 0.05 compared with the pretraining conditions.
(438.4 ± 31.3 g), HFr (441.3 ± 27.5 g) and HFr-Ex (424.7 ± 27.8 g). There was no difference among the groups in relationship to energy intake: CT (89.7 ± 11.1 kcal day −1 ), CT-Ex (93.2 ± 1.6 kcal day −1 ), HFr (97.4 ± 2.8 kcal day −1 ) and HFr-Ex (95.1 ± 9.5 kcal day −1 ). Moreover, there was no interaction between diet and exercise for BM gain (F = 0.01, P = 0.96) and energy intake (F = 0.03, P = 0.85).
Exercise training
No significant baseline differences were observed for the maximal speed among the groups (Table 1) . After 8 weeks of training, the post-training maximal speed that the rats could exercise on the treadmill was diminished in the HFr group (Table 1) compared with the CT (−36.7%, P < 0.05) and CT-Ex (−50.1%, P < 0.001) groups.
The training groups showed increased post-training maximal speed compared with untrained groups (CT versus CT-Ex +28.7%, P < 0.05; HFr versus HFr-Ex +102.1%, P < 0.001; CT versus HFr-Ex +29.7%, P < 0.05). Exercise training increased the final maximal speed in relationship to baseline (CT-Ex +30.9%, P < 0.05; HFr-Ex 33.3%, P < 0.01), whereas the HFr group showed a decreased final to initial maximal speed (−33.6%, P < 0.01). In addition, there was a significant interaction effect between diet and exercise (F = 8.83, P < 0.01).
Insulin sensitivity and metabolic data
There were no significant differences in fasting glucose concentrations (F = 1.69, P = 0.20) among the groups (Table 1) . However, hyperinsulinaemia (F = 4.91, P = 0.0064) was observed in the HFr group compared with the CT group (+146.1%, P < 0.05) and the CT-Ex group (+196.3%, P < 0.01). After a 5 h fast, K i (F = 1.11, P = 0.36) was not significantly different among groups, although we could observe a tendency towards reduction in the HFr group (Table 1) .
The amount of serum TAGs (F = 7.74, P = 0.0006) was higher in the HFr group compared with the CT (+91.4%, P < 0.01), CT-Ex (+78.1%, P < 0.01) and HFr-Ex (+104.9%, P < 0.01) groups (Table 1) .
Liver
The HFr rats showed hepatomegaly (F = 5.36, P = 0.0025) compared with CT rats (HFr +15.4%, HFr-Ex +14.0%, P < 0.01; Table 1 ). The HFr group showed higher hepatic glycogen contents (F = 3.98, P = 0.023) compared with the CT (+115.0%) and CT-Ex (+104.8%) groups (P < 0.05; Table 1 ). The glycogen contents in the HFr-Ex rats were less elevated than in the HFr rats but were not significantly different. The results of the hepatic TAG (F = 6.01, P = 0.0055) analysis were similar to those of the serum TAG analysis: the hepatic TAG contents were increased in the HFr group compared with the CT (+114.3%, P < 0.05), CT-Ex (+76.5%, P < 0.05) and HFr-Ex (+114.2%, P < 0.01) groups (Table 1) . Figure 1A and B shows representative images of the liver from the control rats, in which the morphology is characteristic of a healthy liver. Figure 1C shows fructose-induced lipid accumulation in the hepatic parenchyma, in which the HFr group exhibited mild to moderate steatosis. In contrast, exercise training protected the liver from injury (Fig. 1D ) because its morphology closely resembled that of the CT rats. The steatosis level (F = 14.68, P < 0.0001) was higher in the HFr group than the CT (+135.8%, P < 0.001), CT-Ex (+179.3%, Exercise training modulates hepatic renin-angiotensin system P < 0.001) and HFr-Ex (+87.6%, P < 0.01) groups (Table 1) .
Serum and liver ACE and ACE2 activities
As shown in Fig. 2 , both serum ACE activity ( Fig. 2A ; F = 0.44, P = 0.73) and ACE2 activity ( Fig. 2B ; F = 1.45, P = 0.26) did not change, while a tendency was found for an increase in the ACE/ACE2 serum activity ratio (F = 3.40, P = 0.058) in the HFr group (CT versus HFr, P = 0.08; Fig. 2C) .
Differently from the systemic RAS, liver ACE activity (F = 4.09, P = 0.02) increased in HFr rats compared with the CT-Ex (+169.3%, P < 0.05) and HFr-Ex (+199.6%, P < 0.05) groups (Fig. 2D) . The liver ACE2 activity (F = 1.27, P = 0.31) was not significantly different among groups (Fig. 2E) . The ACE/ACE2 liver activity ratio (F = 9.03, P = 0.0006) was higher in the HFr group than in the CT (+161.9%, P < 0.01), CT-Ex (+189.5%, P < 0.01) and HFr-Ex (+214.3%, P < 0.01) groups (Fig. 2F ).
Western blotting analyses
Renin-angiotensin system axis. ACE hepatic expression (F = 4.20, P = 0.02) in the training groups was similar to that of the CT group; the HFr group had the largest ACE protein expression (P < 0.05, Fig. 3A and B) . No differences were detected in AT1R protein levels (F = 0.25, P = 0.86) between the groups (Fig. 3A and C) .
The HFr group had ACE2 expression levels (F = 6.11, P = 0.0033) lower than the CT (P < 0.05), CT-Ex and HFr-Ex (P < 0.01) groups (Fig. 3A and D) . The Mas receptor expression (F = 3.98, P = 0.017) was significantly lower in the HFr group than in the training groups (P < 0.05, Fig. 3A and E) .
The ACE/ACE2 protein expression ratio (F = 8.35, P = 0.0007; Fig. 3F ) in the HFr group was higher than that in the CT (+81.2%), CT-Ex (+99.9%) and HFr-Ex (+102.5%) groups (P < 0.01 in all cases). Likewise, the AT1R/Mas receptor protein level ratio (F = 4.91, P = 0.0084) was higher in the HFr rats compared with the CT (+55.4%, P < 0.05), CT-Ex (+85.6%, P < 0.01) and HFr-Ex (+58.3%, P < 0.05) rats (Fig. 3G) .
Hepatic glucose output. The PEPCK hepatic expression (F = 5.86, P = 0.0061) was greater in the HFr rats than in the CT (P < 0.05) and HFr-Ex (P < 0.01) rats ( Fig. 4A and  B) . The G6Pase expression levels (F = 0.56, P = 0.65) were not significantly different between the groups (Fig. 4A and  C) . Additionally, the GLUT2 (F = 4.22, P = 0.0091; Fig. 4A and D) expression levels were increased in the HFr group compared with other groups (P < 0.05 in all cases). 
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Pro-inflammatory cytokines in liver.
The HFr IL-6 expression (F = 3.02, P = 0.05) was significantly elevated compared with the CT rats (P < 0.05). Interleukin-6 did not fully normalize to the level of the CT group in training rats ( Fig. 5A and B) . The TNF-α expression (F = 6.71, P = 0.0031) was also markedly increased in HFr rats compared with the CT (P < 0.01), CT-Ex and HFr-Ex rats (P < 0.05 in both cases; Fig. 5A and C) .
Quantification of angiotensin
The liver Ang II concentration (F = 6.71, P = 0.0043) was higher in the HFr group than in the CT (+983.1%, P < 0.01), CT-Ex (+627.3%, P < 0.01) and HFr-Ex (+164.9%, P < 0.05) groups (Fig. 6A) . The liver Ang(1-7) concentration (F = 3.61, P = 0.038) was increased in HFr-Ex rats compared with the HFr rats (+313.6%, P < 0.05; Fig. 6B ). The Ang II/Ang(1-7) liver ratio (F = 35.08, P < 0.0001) in the training groups was similar to that of the CT group; the HFr group had the highest Ang II/Ang(1-7) liver ratio (P < 0.0001; Fig. 6C ).
Discussion
The main new findings of the present study are that exercise training in a fructose overloaded model has the following effects: (i) it normalizes ACE activity and protein expression and Ang II concentration in hepatic tissue; (ii) it increases ACE2 protein expression, followed by higher levels of Ang (1-7) and Mas receptor in the liver; (iii) it decreases the ACE/ACE2, Ang II/Ang(1-7) and AT1R/Mas receptor ratios towards normal values in liver tissue; and (iv) it does not change the systemic RAS. Although some studies have shown that the RAS can participate in liver diseases related to MS, they did not measure the hepatic RAS components. Therefore, for the first time, our study provides evidence that exercise training modulates the hepatic RAS (enzyme activity and protein expression, peptide concentration and receptor protein expression), which can contribute to reducing the progression of metabolic dysfunction and NAFLD.
Our study confirms that fructose-fed rats did not develop increased BM compared with the control group (Botezelli et al. 2012; Magliano et al. 2015) . However, the effects of fructose seem, in part, to be independent of increases in BM, because the rats showed liver injuries and subclinical metabolic alterations (Medeiros et al. 2016) .
It is important to note that the final aerobic capacity was decreased in untrained HFr rats in relationship to CT rats, unlike the exercise-trained HFr rats. Therefore, the exercise training on a motor treadmill, at a moderate intensity during 8 weeks, increased the final maximal speed, suggesting improved aerobic capacity in these exercised-trained animals (Botezelli et al. 2012; Medeiros et al. 2016) . We observed hyperinsulinaemia in the presence of normal glucose concentrations in the HFr group. It is possible that the hyperinsulinaemia was not high enough to elicit significant changes in the insulin sensitivity, leading to subclinical IR, because the HFr group indicated altered hepatic glucose metabolism (Medeiros et al. 2016) . However, the intervention of exercise recovers hyperinsulinaemia and ameliorates insulin sensitivity to levels similar to the control animals, preventing the development of a prediabetic state (Kawamura et al. 2002; Machado et al. 2014) . Aerobic exercise training may effectively mitigate fructose-induced MS in rats, and it has been shown that it reduces visceral fat, increases high-density lipoprotein-cholesterol, lowers plasma TAG and insulin concentrations and improves the homeostasis model assessment of insulin resistance (HOMA-IR) and insulin signalling (Boa et al. 2014; Stanišić et al. 2016) .
The sedentary fructose-fed animals exhibited hepatomegaly, moderate steatosis and high serum and hepatic TAG concentrations. In addition, these animals exhibited disorganized hepatic histoarchitecture, which is typically associated with IR and a low-grade inflammatory state, altered TAG synthesis, transport through peripheral lipolysis and the storage of lipids outside of adipose tissue (lipotoxicity), altogether leading to excessive hepatic influx of fatty acids (Kawamura et al. 2002; Kawasaki et al. 2009 ). Additionally, this is related to the stimulation of lipogenic enzymes and the inhibition of mitochondrial β-oxidation, thus contributing to the development of NAFLD (Frantz et al. 2014) . These findings in the HFr group were lessened by exercise training, reverting hepatic steatosis, TAG accumulation and restoring the morphology of the hepatic parenchyma.
One new finding from this study is that fructose overload increased the hepatic ACE activity and protein expression and Ang II concentration, but this not followed by higher levels of AT1R protein expression. Previous studies showed that the ACE/Ang II/AT1R axis is upregulated in rat liver fibrosis and is involved 
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in inflammation, accumulation of TAGs in the liver, decreased fatty acid oxidation and interference in several steps of intracellular insulin signalling (Matthew Morris et al. 2013; Moreira de Macêdo et al. 2014) . However, the exercise training restored the hepatic ACE and Ang II levels, suggesting an association between the beneficial effect produced by exercise training on hepatic metabolism and the normalization of the ACE/Ang II/AT1R axis.
In addition, HFr rats showed the most deleterious expression of the ACE2/Ang(1-7)/Mas receptor axis. ACE2 is expressed in primary organs implicated in IR and exhibits its tissue-protective effects not only by decreasing Ang II but also by producing Ang(1-7) (Bindom et al. 2010; Frantz et al. 2013) . In line with this hypothesis, the ACE2/Ang(1-7)/Mas axis deficiency in FVB/N mice induced glucose intolerance, dyslipidaemia, increased insulin concentrations and reduced insulin sensitivity (Santos et al. 2008b) . Corroborating these data, the ACE2/Ang(1-7)/Mas axis increases glucose uptake, enhances glucose tolerance and insulin sensitivity, decreases glycogen synthesis and reduces stress in hepatic cells by improving hepatic IR through the protein kinase B (Akt)/phosphatidylinositol 3-kinase (PI3K)/insulin receptor substrate (IRS-1) insulin signalling pathway (Cao et al. 2014 (Cao et al. , 2016 . Therefore, the increase in hepatic ACE2/Ang(1-7)/Mas receptor levels could probably counteract the deleterious effect in this model because exercise training played an important role in restoring this axis to normal levels when compared with untrained littermates.
Another new finding of this study is that the fructose-fed rats increased their hepatic ACE/ACE2 (activity and protein expression), Ang II/Ang(1-7) concentration and AT1R/Mas receptor (protein expression) ratios, suggesting an imbalance in the hepatic RAS towards the classical axis. Both effects were opposed in the exercise training group, indicating a switch in the ACE/Ang II/AT1R towards an increase in the ACE2/Ang(1-7)/Mas receptor axis in exercise-trained rats. These results provide evidence that exercised animals were less susceptible to the deleterious actions of the ACE/Ang II/AT1R axis and that the increase of the ACE2/Ang(1-7)/Mas receptor axis could contribute to the above-mentioned protection against liver damage and maintenance of insulin sensitivity. Moreover, we did not observe alterations in serum ACE and ACE2 activity, and the most important effects of enzymes are expected to happen locally in the tissue, in close proximity to the receptors (AT1R and Mas). Here, we provide evidence that local hepatic RAS changes are independent of the systemic RAS.
Additionally, previous studies have also reported that Ang II increases hepatic glucose production, which could also contribute to IR (Kalupahana et al. 2012) . We examined the expression of PEPCK, G6Pase and GLUT2 proteins in the liver, all of which are involved in gluconeogenesis and glucose uptake/output. The fructose-fed rats showed higher expression levels of PEPCK and GLUT2, suggesting that gluconeogenesis is stimulated and responsible, in part, for the perturbation of whole-animal glucose homeostasis (Caton et al. 2011; Schultz et al. 2013) . Moreover, fructose is used faster than glucose, and more is converted to liver glycogen, thus an increase in the hepatic glycogen concentration was shown by us and others (Décombaz et al. 2011; Basaranoglu et al. 2013) in this model. All of these parameters were significantly attenuated in exercised-trained rats, indicating that maintenance of glucose homeostasis might be involved in the beneficial effects of physical training in metabolic diseases (Boa et al. 2014; Machado et al. 2014) .
In the same way, modulations of the RAS by exercise training can result in the overall suppression of the inflammatory process associated with fructose ingestion (Bidwell et al. 2014) . This might be attributable to TNF-α and IL-6, cytokines that both play a crucial role in systemic and local inflammation and are produced in pathophysiological states such as obesity and NAFLD (Matthew Morris et al. 2013) . Tumour necrosis factor-α also plays a role in antagonizing the effects of adiponectin, disturbs the lipid profile and disrupts the insulin signalling cascade at the level of IRS-1 (Basaranoglu et al. 2013) . Interestingly, in Ang II-infused rats, IL-6 expression was increased in the liver, with associated increases in monocyte recruitment and overall inflammation (Moreno et al. 2009 ). This leads us to speculate that exercise training might downregulate the RAS in pathological conditions, which might, at least in part, contribute to improved insulin sensitivity, reduced hepatic steatosis and inflammation.
One of the limitations of the present study is that we did not provide proof of antibody specificity. For example, Benicky et al. (2012) demonstrated that the AT1R antibody used is non-specific. However, this drawback does not exclude the results found by this work, as demonstrated by the ACE activity and protein level and Ang II concentration in the liver. In addition, further studies are necessary to clarify whether the effects of exercise on metabolism can be blocked with a Mas receptor antagonist.
For the first time, the present study measured the modulation of local hepatic RAS components by exercise training in rats fed a fructose-enriched diet. Here, we provide evidence of association of the hepatic RAS components with exercise training, an important non-pharmacological therapeutic strategy to combat IR and liver diseases by reducing liver lipid accumulation, improving gluconeogenesis and reducing inflammatory mediators. Originally, we showed a downregulation of the pathological hepatic RAS components (ACE/Ang II/AT1R axis) and an elevation of the beneficial counter-regulatory (ACE2/Ang(1-7)/Mas) axis to levels similar to those observed in the control group. These findings argue in favour of compensatory adaptations in the local RAS to maintain the homeostasis in trained animals. Further experimental and clinical studies are needed to clarify the precise mechanisms of exercise training in NAFLD, but these findings strengthen the recommendation for exercise training in the treatment of MS.
